Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 6/20 | 0.47 |
| ▸ | S1PR1 | P21453 | 6/20 | 0.47 |
| ▸ | S1PR3 | Q99500 | 6/20 | 0.47 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.47 |
| ▸ | LAP3 | P28838 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.37 |
| ▸ | FDPS | P14324 | 3/20 | 0.35 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2959705 | 0.81 | CYP1A2 (0.41) | ALDH1A1LPAR2LPAR3 | |
| SCHEMBL9702638 | 0.79 | PPARD (0.46) | ALDH1A1LPAR2LPAR3 | |
| SCHEMBL9701504 | 0.79 | PPARD (0.46) | ALDH1A1LPAR2LPAR3 | |
| SCHEMBL9700806 | 0.79 | PPARD (0.46) | ALDH1A1LPAR2LPAR3 | |
| Water SCHEMBL9701709 | 0.78 | PPARD (0.44) | ALDH1A1LPAR2LPAR3 | |
| SCHEMBL7528050 | 0.77 | LMNA (0.48) | — | |
| SCHEMBL9701509 | 0.77 | PPARD (0.47) | TDP1LPAR2LPAR3 | |
| SCHEMBL5701863 | 0.77 | S1PR2 (0.42) | S1PR2S1PR1S1PR3S1PR4LAP3 | |
| SCHEMBL9702696 | 0.74 | LPAR3 (0.47) | ALDH1A1LPAR2LPAR3 | |
| SCHEMBL5701859 | 0.73 | S1PR2 (0.37) | S1PR2S1PR1S1PR3S1PR4LAP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1485391-B1 | PHOSPHATE TRANSPORT INHIBITORS | GENZYME CORP (US) | 2006-08-23 | — | — | EP | disclosed |